Ironwood Pharmaceuticals

IRWD · NASDAQ🇺🇸

Overview

Earnings Dividends Seasonality Metrics

Reported earnings about 1 month ago

Total Revenue

$47.7M

Previous year: $90.5M

U.S. LINZESS Net Sales

$163M

Previous year: $223M

-26.8%

LINZESS Prescription Demand Growth

13%

LINZESS Commercial Margin

Loading...

Ironwood Pharmaceuticals

Unlock previous datapoints

Upgrade

Ironwood Pharmaceuticals

Unlock previous datapoints

Upgrade

Ironwood Pharmaceuticals Revenue by Segment

Revenue by Segment

LINZESS Collaboration Revenue

CapyFin.com

Royalties & Other Revenue

CapyFin.com

Historical Earnings Impact

Analyze how earnings announcements historically affect stock price performance

Avg. Return Before/After Earnings

Loading earnings performance data...

Loading earnings reaction data...

Key Statistics

Market Cap

$499M

P/E Ratio

12.24

Sector

N/A

Industry

N/A

52-Week High

$5.37

52-Week Low

$0.536

U.S. LINZESS Net Sales

$163M

LINZESS Prescription Demand Growth

13%

LINZESS Commercial Margin

54%

LINZESS Capsules Dispensed

63M

Products

Get in Touch

Resources

Ironwood Pharmaceuticals

Ironwood Pharmaceuticals

Ironwood Pharmaceuticals

Ironwood Pharmaceuticals Revenue by Segment

Revenue by Segment

LINZESS Collaboration Revenue

Royalties & Other Revenue

Historical Earnings Impact

Avg. Return Before/After Earnings

Key Statistics